Home NDC 54771-8174-3 NDC 54771-8174-3 - Draxxin This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 54771-8174
Requested NDC 54771-8174-3
Package NDCs from labels 54771-8174-1, 54771-8174-2, 54771-8174-3, 54771-8174-4
Manufacturer Zoetis Inc.
Effective date 2026-01-27
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 54771-8174-1 Draxxin 50 mL in 1 VIAL, GLASS INJECTION, SOLUTION 50 11 54771-8174-2 Draxxin 100 mL in 1 VIAL, GLASS INJECTION, SOLUTION 100 11 54771-8174-3 Draxxin 250 mL in 1 VIAL, GLASS INJECTION, SOLUTION 250 11 54771-8174-4 Draxxin 500 mL in 1 VIAL, GLASS INJECTION, SOLUTION 500 11
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 54771-8174 DRAXXIN (TULATHROMYCIN) INJECTION, SOLUTION [ZOETIS INC.] 8 4 package rows 20220209_258f413b-95e0-4082-a150-85af60b2af80.zip
DailyMed Socrata Ingredients# Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.